Cargando…
Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1
In hepatocellular carcinoma (HCC) patients with extrahepatic metastasis, the lung is the most frequent site of metastasis. However, how the lung microenvironment favors disseminated cells remains unclear. Here, it is found that nidogen 1 (NID1) in metastatic HCC cell‐derived extracellular vesicles (...
Autores principales: | Mao, Xiaowen, Tey, Sze Keong, Yeung, Cherlie Lot Sum, Kwong, Ernest Man Lok, Fung, Yi Man Eva, Chung, Clive Yik Sham, Mak, Lung‐Yi, Wong, Danny Ka Ho, Yuen, Man‐Fung, Ho, James Chung Man, Pang, Herbert, Wong, Maria Pik, Leung, Carmen Oi‐Ning, Lee, Terence Kin Wah, Ma, Victor, Cho, William Chi‐Shing, Cao, Peihua, Xu, Xiaoping, Gao, Yi, Yam, Judy Wai Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640351/ https://www.ncbi.nlm.nih.gov/pubmed/33173740 http://dx.doi.org/10.1002/advs.202002157 |
Ejemplares similares
-
Tumour extracellular vesicle‐derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement‐dependent cytotoxicity of tumour cells
por: Mao, Xiaowen, et al.
Publicado: (2020) -
Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
por: Wong, Samuel Wan Ki, et al.
Publicado: (2023) -
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019) -
TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis
por: Liu, Bonnie Hei Man, et al.
Publicado: (2021) -
First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
por: Mak, Lung-Yi, et al.
Publicado: (2021)